March 24, 2020 / 12:13 PM / 4 days ago

BRIEF-Oncoquest Announces Publication Of Two Reports Related To Oregovomab Phase 2 Clinical Trial

March 24 (Reuters) - Quest Pharmatech Inc:

* ONCOQUEST ANNOUNCES PUBLICATION OF TWO REPORTS RELATED TO OREGOVOMAB PHASE 2 CLINICAL TRIAL, THE COMPANY’S LEAD INVESTIGATIONAL DRUG IN FRONTLINE OVARIAN CANCER

* QUEST PHARMATECH INC - CURRENTLY PLANNING TO LAUNCH A PHASE 3 TRIAL IN Q2 2020. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below